|
| Groups |
| |
Antigens | Control (n = 10) | Non-Muscle Invasive (n = 10) | Muscle Invasive (n = 10) | |
CD44 | 1 (15.0%) | 2 (54.1%)* | 3 (71.2%)* | |
CD117 | 1 (22.9%) | 1 (33.5%) | 1 (27.6%) | |
CD133 | 1 (5.0%) | 2 (34.0%)* | 3 (94.5%)* | |
ABCG2 | 0 (0.0%) | 3 (94.8%)* | 3 (97.4%)* | |
TLR2 | 3 (96.2%)* | 1 (11.2%) | 0 (0.0%) | |
TLR4 | 3 (87.4%)* | 1 (10.3%) | 1 (12.1%) | |